More than 300,000 children and youth in Ontario have

one or more neurodevelopment disorders.

At POND, we are here to address the clear and urgent need for new and

better targeted therapies in an effort to improve the long-term outcomes

for children with ASD, ADHD, OCD, ID, Rett Syndrome, Tourette Syndrome,

Fragile X Syndrome, and Down Syndrome.

Leave a Reply

Your email address will not be published. Required fields are marked *